Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095–1097

Detalles Bibliográficos
Autores principales: Ziegler, Dan, Tesfaye, Solomon, Kempler, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2012
Materias:
Online Letters: Comments and Responses
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476903/
https://www.ncbi.nlm.nih.gov/pubmed/23093690
http://dx.doi.org/10.2337/dc12-0817
_version_ 1782247127670325248
author Ziegler, Dan
Tesfaye, Solomon
Kempler, Peter
author_facet Ziegler, Dan
Tesfaye, Solomon
Kempler, Peter
author_sort Ziegler, Dan
collection PubMed
description
format Online
Article
Text
id pubmed-3476903
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-34769032013-11-01 Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095–1097 Ziegler, Dan Tesfaye, Solomon Kempler, Peter Diabetes Care Online Letters: Comments and Responses American Diabetes Association 2012-11 2012-10-13 /pmc/articles/PMC3476903/ /pubmed/23093690 http://dx.doi.org/10.2337/dc12-0817 Text en © 2012 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Online Letters: Comments and Responses
Ziegler, Dan
Tesfaye, Solomon
Kempler, Peter
Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095–1097
title Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095–1097
title_full Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095–1097
title_fullStr Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095–1097
title_full_unstemmed Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095–1097
title_short Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095–1097
title_sort comment on: fraser et al. the effects of long-term oral benfotiamine supplementation on peripheral nerve function and inflammatory markers in patients with type 1 diabetes: a 24-month, double-blind, randomized, placebo-controlled trial. diabetes care 2012;35:1095–1097
topic Online Letters: Comments and Responses
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476903/
https://www.ncbi.nlm.nih.gov/pubmed/23093690
http://dx.doi.org/10.2337/dc12-0817
work_keys_str_mv AT zieglerdan commentonfraseretaltheeffectsoflongtermoralbenfotiaminesupplementationonperipheralnervefunctionandinflammatorymarkersinpatientswithtype1diabetesa24monthdoubleblindrandomizedplacebocontrolledtrialdiabetescare20123510951097
AT tesfayesolomon commentonfraseretaltheeffectsoflongtermoralbenfotiaminesupplementationonperipheralnervefunctionandinflammatorymarkersinpatientswithtype1diabetesa24monthdoubleblindrandomizedplacebocontrolledtrialdiabetescare20123510951097
AT kemplerpeter commentonfraseretaltheeffectsoflongtermoralbenfotiaminesupplementationonperipheralnervefunctionandinflammatorymarkersinpatientswithtype1diabetesa24monthdoubleblindrandomizedplacebocontrolledtrialdiabetescare20123510951097

Ejemplares similares